JUN and hearing loss disorder: Understanding the mode of action of JNK/c-Jun signaling in the injured cochlea is important, taking into account the current aim to develop a pharmacological therapy against hearing loss by inhibiting the interaction between JNKs and their targets (Borsello et al., 2003; Suckfuell et al., 2014).